Joseph Pergolizzi
Pain Medicine · Naples, FLNPI 1922198068
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 27.5% of the total. Reporting peaked in 2019 at $146,214 and has fallen 84.5% since, to $22,638 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $1083.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$91K
- Biodelivery Sciences International, Inc.$64K
- Scilex Pharmaceuticals Inc.$41K
- Bausch Health US, LLC$40K
- Daiichi Sankyo Inc.$23K
- MDD US Operations, LLC$12K
- plus $60K from 19 others
Across 32 payments — averaging $54,352 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hikma Pharmaceuticals USA$1.6M
- Purdue Pharma L.p.$100K
- Bausch Health US, LLC$72K
- GE HealthCare$5K
What the payments were for
- Consulting fees$92,55328%
- Speaking & faculty fees$194,94859%
- Travel & lodging$39,06212%
- Food & beverage$6,0992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 106 | $91,453 |
| Biodelivery Sciences International, Inc. | 87 | $64,254 |
| Scilex Pharmaceuticals Inc. | 35 | $41,072 |
| Bausch Health US, LLC | 2 | $40,460 |
| Daiichi Sankyo Inc. | 18 | $23,250 |
| MDD US Operations, LLC | 14 | $11,837 |
| Janssen Research & Development, LLC | 7 | $9,014 |
| Teva Pharmaceuticals USA, Inc. | 1 | $8,550 |
| Vertex | 6 | $7,673 |
| Bayer Healthcare LLC | 2 | $5,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $5,250 |
| Heron Therapeutics, Inc. | 4 | $4,649 |
| Regeneron | 5 | $3,975 |
| Tris Pharma Inc | 5 | $3,802 |
| Lilly USA, LLC | 1 | $3,600 |
| Angelini Pharma Inc. | 1 | $2,500 |
| Kowa Pharmaceuticals America, Inc. | 1 | $2,500 |
| Acadia Pharmaceuticals Inc | 1 | $2,138 |
| Collegium Pharmaceutical, Inc. | 3 | $253 |
| Brixton Biosciences, Inc. | 1 | $239 |
| GRT US Holding, Inc. | 2 | $194 |
| Averitas Pharma Inc. | 1 | $90 |
| Tonix Medicines, Inc. | 1 | $84 |
| Hikma Pharmaceuticals USA | 1 | $42 |
| AstraZeneca | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELISTOR$81,398
- BELBUCA$62,615
- APLENZIN$40,460
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH$23,755
- Morphabond ER$23,083
- LUCEMYRA$18,335
- ZTLido$16,800
- Lucemyra/Lofexidine$11,289
- JOURNAVX$7,557
- CINVANTI$4,649
- Seglentis$2,500
- MYOBLOC$500
- APOKYN$500
- Xadago$500
- Neural Ice$239
- XTAMPZA$221
- Qutenza$150
- Dyanavel XR$120
How this compares
$332,662 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Naples
- Jeffrey GudinMiami$356K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
- Melanie RosenblattBoca Raton$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.